Profile photo Floriaan Schmidt

Floriaan Schmidt

Associate Professor

Biography

A. Floriaan Schmidt has received training in public health, clinical epidemiology, and mathematics. Floriaan completed a PhD on methods for personalized medicine with the Utrecht University in the Netherlands. Following his PhD, he accepted a position with University College London (UCL). Currently, Floriaan has a joined position with UMC Utrecht and UCL. His research focusses on developing and applying human genetics for drug target validation (Schmidt, Nature Communications 2020 & 2021). Additionally, Floriaan conducts research to improve risk prediction modelling for patient subgroups by integrating electronic healthcare records data with information from multi-model sources including genomics and metabolomics. Floriaan has received funding from the British Heart Foundation, the National Institute for Health Research University College London Hospitals Biomedical Research Centre, Servier, IMI, and Erasmus+.

Recent publications

Influence of stressful life events and personality traits on PLN cardiomyopathy severity E van Drie, S E L Taal, A F Schmidt, T E Verstraelen, R de Brouwer, D Schoormans, P M C Mommersteeg, R A de Boer, A A M Wilde, F W Asselbergs, A F Baas, J P van Tintelen, L M van den Heuvel
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2024, vol. 26
Advancing drug development for atrial fibrillation by prioritising findings from human genetic association studies Kishore Kukendrarajah, Aliki Eleni Farmaki, Pier D. Lambiase, Richard Schilling, Chris Finan, Amand Floriaan Schmidt, Rui Providencia
EBioMedicine, 2024, vol. 105
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders A. Floriaan Schmidt, Chris Finan, Sandesh Chopade, Stephan Ellmerich, Martin N. Rossor, Aroon D. Hingorani, Mark B. Pepys
Open Biology, 2024, vol. 14
Prioritising genetic findings for drug target identification and validation Nikita Hukerikar, Aroon D. Hingorani, Folkert W. Asselbergs, Chris Finan, Amand F. Schmidt
Atherosclerosis, 2024, vol. 390
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity Mark Jansen, A F Schmidt, J J M Jans, I Christiaans, S N van der Crabben, Y M Hoedemaekers, D Dooijes, J D H Jongbloed, L G Boven, R H Lekanne Deprez, A A M Wilde, J van der Velden, R A de Boer, J P van Tintelen, F W Asselbergs, A F Baas
Journal of Cardiovascular Translational Research, 2023, vol. 16, p.1267-1275
Causal inference and non-randomized experiments Michail Katsoulis, Nandita Mitra, A. Floriaan Schmidt
2023, p.109-123

External positions

Onderzoeker - Onderzoeker - University College London